Revision history of "ROLE OF UROGUANYLINA IN THE REGULATION OF ENERGY HOMEOSTASIS." (Q3144293)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

8 October 2024

  • curprev 23:5423:54, 8 October 2024DG Regio talk contribs 64,863 bytes +5 Changed label, description and/or aliases in pt
  • curprev 23:5423:54, 8 October 2024DG Regio talk contribs 64,858 bytes +3 Set a claim value: summary (P836): Uroguanylina (UGN) foi proposto como parte do eixo gastrointestinal cérebro-tracção. Dados não publicados do nosso grupo mostraram que a administração de NGU a animais obesos induz a diminuição do peso corporal e da massa gorda, independentemente da ingestão. Cenário: A UGN pode ser um bom alvo farmacológico para o tratamento da obesidade e as alterações em seus níveis estão relacionadas à obesidade infantil e adulta. Objectivos: Estudiar:1.El efeit...

12 March 2024

20 December 2023

12 June 2023

10 June 2023

17 August 2022

  • curprev 20:5620:56, 17 August 2022DG Regio talk contribs 63,583 bytes +42,619 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

2 December 2021

  • curprev 15:3015:30, 2 December 2021DG Regio talk contribs 14,201 bytes +2,222 Created claim: summary (P836): Uroguanylina (UGN) a été proposé dans le cadre de l’axe gastro-tracte du cerveau. Des données inédites de notre groupe ont montré que l’administration de NGU à des animaux obèses induit une diminution du poids corporel et de la masse grasse indépendamment de l’apport. Scénario: L’UGN peut être une bonne cible pharmacologique pour le traitement de l’obésité et les altérations de ses niveaux sont liées à l’obésité infantile et adulte. Objectifs:...
  • curprev 15:3015:30, 2 December 2021DG Regio talk contribs 11,979 bytes +135 Changed label, description and/or aliases in fr: translated_label

12 October 2021

  • curprev 14:0114:01, 12 October 2021DG Regio talk contribs 11,844 bytes +120 Changed label, description and/or aliases in en: translated_label
  • curprev 14:0114:01, 12 October 2021DG Regio talk contribs 11,724 bytes +1,988 Created claim: summary (P836): Uroguanylina (UGN) has been proposed as part of the gastrointestinal brain-tract axis. Unpublished data from our group have shown that administration of NGU to obese animals induces decreased body weight and fat mass independent of intake. Scenario: the UGN can be a good pharmacological target for the treatment of obesity and alterations in its levels are related to childhood and adult obesity. Objectives: Estudiar:1.El pharmacological effect o...

10 October 2021

9 October 2021

8 October 2021